You are here: Industry Insights > SMC

News List

SMC approves funding for four new medicines on the NHS pharmatimes
February 09, 2021
In its February 2021 meeting, the Scottish Medicines Consortium (SMC) has accepted four new medicines for use by the NHS in Scotland.
SMC kicks of the new year by accepting five new medicines for NHS use pharmatimes
January 20, 2021
Five newly licensed medicines have been accepted for use on NHS Scotland by the Scottish Medicines Consortium (SMC) following its first meeting of 2021.
Inhaled Ampion Advances to Second Group of COVID-19 Patients with Respiratory Distress americanpharmaceuticalreview
November 23, 2020
Ampio Pharmaceuticals announced the second group in the Phase I inhaled Ampion™ clinical study is being treated following clearance by the Safety Monitoring Committee (SMC) who found Ampion to be safe and well-tolerated after reviewing the results from ..
Waylivra, Tecentriq and more accepted by SMC pharmatimes
November 11, 2020
The Scottish Medicines Consortium has published guidance on eight new medicines, accepting seven of those and rejecting one for use by NHS Scotland in its November meeting.
NICE recommends Novartis’ Mayzent on the heels of SMC approval pharmatimes
October 16, 2020
The National Institute for Health and Care Excellence (NICE) has recommended Novartis’ Mayzent for use by NHS England, only a few days after the Scottish Medicines Consortium (SMC) approved the multiple sclerosis (MS) drug.
Bavencio, Imbruvica among latest SMC decisions pharmatimes
October 15, 2020
In its latest guidance, the Scottish Medicines Consortium (SMC) has accepted eight new medicines for use by NHS Scotland.
SMC accepts 14 new medicines for use by NHS Scotland pharmatimes
September 17, 2020
Fourteen newly licensed medicines have been accepted for use on NHS Scotland by the Scottish Medicines Consortium (SMC), bringing a raft of new treatment options for conditions including epilepsy, depression and cancer.
SMC accepts Janssen’s ulcerative colitis drug Stelara for NHS use pharmaceutical-technology
April 17, 2020
Scottish Medicines Consortium (SMC) has accepted Janssen Pharmaceutical’s Stelara (ustekinumab) for use on the National Health Service (NHS) Scotland to treat moderately to severely active ulcerative colitis (UC) in adults.
SMC accepts four medicines for NHS use pharmatimes
April 15, 2020
Biogen’s Fampyra (fampridine) has become the first treatment funded by NHS Scotland to improve walking difficulties in adult patients with all types of multiple sclerosis (MS).
Scottish Medicines Consortium approves Kymriah® CAR-T therapy europeanpharmaceuticalreview
September 12, 2019
The Kymriah (tisagenlecleucel) treatment has received a positive appraisal from the Scottish Medicines Consortium, after EMA approval last year.

Previous page 1 2 3 4 Next page